ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

N4P N4 Pharma Plc

0.80
0.00 (0.00%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 6,637 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.40 1.45M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.80p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.10p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.45 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.40.

N4 Pharma Share Discussion Threads

Showing 7426 to 7445 of 8600 messages
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older
DateSubjectAuthorDiscuss
13/11/2020
21:08
They are aiming to gain enough data to allow commercial talks to begin but theoretically they could license it out now, although I doubt they’d achieve the sums of money they have in mind at this stage! The patent needs finalising and this could be the only reason we ain't getting the finer detail passed to investors that we’d normally see, they state the patio likely to be given in full before year end.

The did always plan to be in the clinic for 2020 and I’d like to think this is still on track but obviously the delays and difficulties seen with the pandemic may dictate differently. Most investors know these things take time, sadly the traders want the deals before it’s ready.

featherby81
13/11/2020
21:06
Longer term the best company I have ever seen is OPTI. I have no idea when the market will realise their absolutely massive potential but it surely will at some point. Not really a Pharma but their products have been subject to clinical trials and have fantastic scientific evidence backing them.
nobbygnome
13/11/2020
21:05
Short term STX is the best buy IMHO. A US licensing deal for their approved product gunning for a $billion market is imminent. I am expecting a good 40% upside when this is announced although of course it does depend on the terms to some degree.

No investment advice intended....

nobbygnome
13/11/2020
21:01
Thank you Nobby. First time I’ve looked seriously at a Pharma given I liked the sound of their product . Also appreciated feather’s response .What in your view are the alternatives I could consider and why? Cheers.
richjj
13/11/2020
20:53
>> Rich

Zero chance of a takeover here, Pharma doesn't gamble on unproven technologies!

nobbygnome
13/11/2020
20:51
>> Barrie

No, I was otherwise engaged trading some serious companies not this dross! You all know my views about N4P so I won't bother to articulate them again.

nobbygnome
13/11/2020
20:49
Thank you feather. Are we talking about possible clinical trials next year in your view if all things come together as planned ? Additionally as this is a relatively small and knowledgable company is there a real risk that they would be taken over by a larger Pharmaceutical company ?
richjj
13/11/2020
20:07
Hi RichJJ
Only my opinion but I’d say we’ll definitely get a decent breakdown of the results from Nigel on the phase 3 covid work, it seems N4 have joined a growing trend of investor updates after a company releases news’s (on AIM.
We’ve got a little way to go until we are safely out of the woods on the coronavirus works, they assume it’ll generate the antibodies and provide a positive outcome but as with every experiment, its not a dead certain outcome until proved.

It’s worth noting the covid study is also being used as a comparative study against other familiar plasmids which is exactly what’s needed to complete the data package. We are looking to gain trust and understanding amongst developers looking to improve on their existing delivery systems, they need to be comfortable N4 know their product and have an understanding on how it can be formulated to fulfil their requirements.

I’m a long term holder and feel there’s significant potential as each stage is proven up, if and when we start clinical (human) trials we won’t be hovering around this £10m MCAP valuation.

featherby81
13/11/2020
17:19
New to N4P but invested as see the potential . When do you think further presentations will follow from the company and how far do you feel the product will develop this year given the possible recent COVID vaccine intentions going into early next year. ?Additionally how far do you see the share price moving in this regard ? Thanks for your insights in advance.
richjj
13/11/2020
11:34
If vaccines are the now, delivery systems are the future:)))
ch1rp
12/11/2020
17:19
Nobbygnome

Tell me you took a punt on these this morning, nobby!!

barrie16
12/11/2020
15:10
Yep, all good in the hood.
jibba jabber
12/11/2020
14:35
Should be pushing up to 8p soon
julianw2
12/11/2020
09:44
Huge rise expectations here:)))
ch1rp
11/11/2020
07:39
"Please don't compare me to Stig. He is foul mouthed and obnoxious."

Can't argue with that :-) but he makes us a shed load of dosh.

In the Stig we Trust.

hodhasharon
11/11/2020
07:38
Isn't anyone else here seriously excited?Nuvec is quietly working it's way successfully through its target tests.Who wants to be jabbed year upon year in defence against cancer or Covid when you could simply take a pill?GET REAL PEEPS!!!
ch1rp
09/11/2020
14:55
Still an interesting prospect. In for another 70k(shares).Will be huge if proven successful Novec IMHO
pwal
09/11/2020
14:40
Pre COVID this is about 4p
Avct about 25p
Then theres sng , that’s a big loss
Don’t panic sell tho because even if they go that low, their still the same companies Doing the same work.

glenglad
09/11/2020
14:36
You should have waited vol, all COVID related shares are collapsing and probably won’t stop untill this vacine is being used.
glenglad
09/11/2020
13:54
Got some more for 5.38p
volsung
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older

Your Recent History

Delayed Upgrade Clock